Strong Leadership Team

Vasilis Paspaliaris
Chief Executive Officer
  • PhD in Pharmacology
  • Founder of 4 biotech companies, and have raised over $30 million
  • Exited companies with >$100 million in sales
  • Multiple awards from American Association of Clinical Endocrinologists and American Academy of Anti-Aging
  • Published over 25 papers, holds 7 patents
David Strawn
Chief Strategy Officer
  • Degree in Finance, and JD Hons
  • Venture capitalist, and attorney for over 40 years
  • Participated in a multitude of roles in early and mid-stage companies in a variety of industries
  • Involved in the development of cross-border PATRIOT Act Compliance Programs
Peter Milonas
Chief Operations Officer
  • Post-graduate degree in Pharmaceuticals
  • Led teams in several sectors including: biotechnology, cosmetic license, ophthalmology, women’s health, gastroenterology, and pharmaceuticals for over 20 years
  • Key driver for the development of businesses for several incorporated technologies of Paspa Pharmaceuticals
  • Multiple awards from American Association of Clinical Endocrinologists and American Academy of Anti-Aging
  • Strong reputation and experience in sales, marketing, and management in numerous healthcare fields
George Kolios
Chief Medical/Scientific Officer
  • Professor of Pharmacology at School of Medicine, Democritus University of Thrace, Greece
  • PhD in Gastroenterology from University of Athens, Greece; PhD in Pharmacology from University of Bath, United Kingdom.
  • Over 130 papers in peer-reviewed journals, cited over 6,000 times, and over 250 invitations to lecture at congress’ world-wide
  • Expert Clinical Gastroenterologist, with extensive work in Immunopharmacology, mucosal immunology, inflammatory bowel disease, and fibrosis

Our Partners

paspa
tithon
summa
promab
uot
uoc
Previous
Next

Copyright © 2022 Ophelos Therapeautics, All rights reserved.